231 related articles for article (PubMed ID: 37649633)
21. An engineered Escherichia coli Nissle strain prevents lethal liver injury in a mouse model of tyrosinemia type 1.
Gu P; Xie L; Chen T; Yang Q; Zhang X; Liu R; Guo J; Wei R; Li D; Jiang Y; Chen Y; Gong W; Chen P
J Hepatol; 2024 Mar; 80(3):454-466. PubMed ID: 37952766
[TBL] [Abstract][Full Text] [Related]
22. Nattokinase enhances the preventive effects of Escherichia coli Nissle 1917 on dextran sulfate sodium-induced colitis in mice.
Liang M; Zhang J; Yang Y; Xia Y; Liu L; Liu L; Wang Q; Gao X
World J Microbiol Biotechnol; 2022 Nov; 39(1):8. PubMed ID: 36350434
[TBL] [Abstract][Full Text] [Related]
23. Development of a Genome-Scale Metabolic Model and Phenome Analysis of the Probiotic
Kim D; Kim Y; Yoon SH
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672760
[No Abstract] [Full Text] [Related]
24. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.
Ukena SN; Singh A; Dringenberg U; Engelhardt R; Seidler U; Hansen W; Bleich A; Bruder D; Franzke A; Rogler G; Suerbaum S; Buer J; Gunzer F; Westendorf AM
PLoS One; 2007 Dec; 2(12):e1308. PubMed ID: 18074031
[TBL] [Abstract][Full Text] [Related]
25. Construction and characterization of a hypervesiculation strain of Escherichia coli Nissle 1917.
Sawabe T; Ojima Y; Nakagawa M; Sawada T; Tahara YO; Miyata M; Azuma M
PLoS One; 2024; 19(4):e0301613. PubMed ID: 38564580
[TBL] [Abstract][Full Text] [Related]
26. Beneficial effects resulting from oral administration of
Souza ELS; Campos CLV; Reis DC; Cassali GD; Generoso SV; Cardoso VN; Azevedo V; Medeiros JD; Fernandes GR; Nicoli JR; Martins FS
Benef Microbes; 2020 Dec; 11(8):779-790. PubMed ID: 33191778
[TBL] [Abstract][Full Text] [Related]
27. Effect of probiotic
Rahayu ES; Mariyatun M; Putri Manurung NE; Hasan PN; Therdtatha P; Mishima R; Komalasari H; Mahfuzah NA; Pamungkaningtyas FH; Yoga WK; Nurfiana DA; Liwan SY; Juffrie M; Nugroho AE; Utami T
World J Gastroenterol; 2021 Jan; 27(1):107-128. PubMed ID: 33505154
[TBL] [Abstract][Full Text] [Related]
28. Modified Prebiotic-Based "Shield" Armed Probiotics with Enhanced Resistance of Gastrointestinal Stresses and Prolonged Intestinal Retention for Synergistic Alleviation of Colitis.
Xie A; Ji H; Liu Z; Wan Y; Zhang X; Xiong H; Nie SP; Wan H
ACS Nano; 2023 Aug; 17(15):14775-14791. PubMed ID: 37477584
[TBL] [Abstract][Full Text] [Related]
29. Pyrroloquinoline quinone-secreting probiotic Escherichia coli Nissle 1917 ameliorates ethanol-induced oxidative damage and hyperlipidemia in rats.
Singh AK; Pandey SK; Naresh Kumar G
Alcohol Clin Exp Res; 2014 Jul; 38(7):2127-37. PubMed ID: 24930470
[TBL] [Abstract][Full Text] [Related]
30. Effect of antibiotic, probiotic, and human rotavirus infection on colonisation dynamics of defined commensal microbiota in a gnotobiotic pig model.
Huang HC; Vlasova AN; Kumar A; Kandasamy S; Fischer DD; Deblais L; Paim FC; Langel SN; Alhamo MA; Rauf A; Shao L; Saif LJ; Rajashekara G
Benef Microbes; 2018 Jan; 9(1):71-86. PubMed ID: 29022385
[TBL] [Abstract][Full Text] [Related]
31. Construction of a sustainable 3-hydroxybutyrate-producing probiotic Escherichia coli for treatment of colitis.
Yan X; Liu XY; Zhang D; Zhang YD; Li ZH; Liu X; Wu F; Chen GQ
Cell Mol Immunol; 2021 Oct; 18(10):2344-2357. PubMed ID: 34480146
[TBL] [Abstract][Full Text] [Related]
32. Genetically Engineered Escherichia coli Nissle 1917 Secreting GLP-1 Analog Exhibits Potential Antiobesity Effect in High-Fat Diet-Induced Obesity Mice.
Ma J; Li C; Wang J; Gu J
Obesity (Silver Spring); 2020 Feb; 28(2):315-322. PubMed ID: 31970910
[TBL] [Abstract][Full Text] [Related]
33. Intestinal effect of the probiotic
Behrouzi A; Mazaheri H; Falsafi S; Tavassol ZH; Moshiri A; Siadat SD
J Diabetes Metab Disord; 2020 Jun; 19(1):597-604. PubMed ID: 32550212
[TBL] [Abstract][Full Text] [Related]
34. Effect of Probiotic E. coli Nissle 1917 Supplementation on the Growth Performance, Immune Responses, Intestinal Morphology, and Gut Microbes of Campylobacter jejuni Infected Chickens.
Helmy YA; Closs G; Jung K; Kathayat D; Vlasova A; Rajashekara G
Infect Immun; 2022 Oct; 90(10):e0033722. PubMed ID: 36135600
[TBL] [Abstract][Full Text] [Related]
35. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice.
de Sant'Ana LP; Ribeiro DJS; Martins AMA; Dos Santos FN; Corrêa R; Almeida RDN; Eberlin MN; Maurice CF; Magalhães KG
Front Immunol; 2019; 10():2926. PubMed ID: 31998283
[TBL] [Abstract][Full Text] [Related]
36. Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice.
Balakumar M; Prabhu D; Sathishkumar C; Prabu P; Rokana N; Kumar R; Raghavan S; Soundarajan A; Grover S; Batish VK; Mohan V; Balasubramanyam M
Eur J Nutr; 2018 Feb; 57(1):279-295. PubMed ID: 27757592
[TBL] [Abstract][Full Text] [Related]
37. Probiotics ameliorate chronic low-grade inflammation and fat accumulation with gut microbiota composition change in diet-induced obese mice models.
Joung H; Chu J; Kim BK; Choi IS; Kim W; Park TS
Appl Microbiol Biotechnol; 2021 Feb; 105(3):1203-1213. PubMed ID: 33443636
[TBL] [Abstract][Full Text] [Related]
38. Effects of a probiotic intervention on Escherichia coli and high-fat diet-induced intestinal microbiota imbalance.
Sun Q; Zhang S; Liu X; Huo Y; Su B; Li X
Appl Microbiol Biotechnol; 2020 Feb; 104(3):1243-1257. PubMed ID: 31853561
[TBL] [Abstract][Full Text] [Related]
39. Probiotic
Chiang CJ; Chao YP; Ali A; Day CH; Ho TJ; Wang PN; Lin SC; Padma VV; Kuo WW; Huang CY
Benef Microbes; 2021 Jun; 12(3):283-293. PubMed ID: 34030609
[No Abstract] [Full Text] [Related]
40. Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery.
Zhou J; Li M; Chen Q; Li X; Chen L; Dong Z; Zhu W; Yang Y; Liu Z; Chen Q
Nat Commun; 2022 Jun; 13(1):3432. PubMed ID: 35701435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
